• Home
  • About
  • All Companies
    • Recent
    • Summary Lists
  • Contact

Epigenic Therapeutics

  • August 18, 2022
  • New Biotech Startups

Founded in 2021, Epigenic Therapeutics is a Chinese startup developing next generation gene editing therapies for a wide variety of diseases, using modulation of the epigenetic genome.

Epigenic Therapeutics’ proprietary technology platform employs artificial intelligence algorithms to explore and obtain an optimized CRISPR-Cas component to regulate target gene(s) or govern the expression of one or multiple gene(s) at once without changing the sequence of the DNA. The company says the platform is capable of overcoming the potential risk rising from DNA cleavage including but not limited to off-target effect, short half-life and challenging patient compliance issues.

Combining a patented lipid nanoparticle (LNP) medicine delivery system, the company’s platform has been proven to precisely and efficiently deliver medicine to target cells and tissues ex vivo and in vivo in ocular, neurodegeneration, metabolic, and rare disease models.

The company raised Series A funding in August 2022 to validate its epigenetic editing in non-human primates, expand expertise and capabilities, and sponsor early-stage clinical investigations. 


Subscribe for alerts on new companies featured on Startups.Bio


September 21, 2023Function Oncology
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond measuring gene sequence to measuring …
July 17, 2023Mallia Therapeutics
Founded in 2023, Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss. sCD83, which was discovered as an immune modulator by Mallia co-founder …
April 21, 2023T-Therapeutics
T-Therapeutics is on a mission to unlock the power of T cells to treat chronic and infectious diseases. Founded in 2022, the company is based on technology from Professor Allan …
March 26, 2023Empyrean Neuroscience
Empyrean Neuroscience has developed a platform for genetically engineering small molecule therapeutics from fungi and plants to treat neuropsychiatric and neurologic disorders. Through precision targeting and engineering of the fungal …

View all recently featured startups


Tags:

© Copyright 2022. Startups.Bio, powered by VentureRadar.